A new clinical trial from Eli Lilly and Company suggests its experimental triple hormone drug, retatrutide, could become one ...

Retatrutide, an experimental injectable drug, targets three hormones related to weight loss.

A new weekly injection may soon transform how millions manage Parkinson’s disease. For over 8.5 million people living with this condition worldwide, daily treatment has meant taking levodopa and ...

People who got the injection, retatrutide, lost 28 percent of their body weight on average after 80 weeks, Eli Lilly said.

Meaghan is an editor and writer who also has experience practicing holistic medicine as an acupuncturist and herbalist. She's passionate about helping individuals live full, healthy and happy lives at ...

CLEVELAND, Ohio — A recent clinical trial led by the University of Cincinnati looked at whether people living with HIV were more likely to take a monthly injection or a daily pill as treatment. The ...

GREENVILLE, S.C.--(BUSINESS WIRE)--Crossroads Treatment Centers (Crossroads), a leading provider of substance use disorder treatment, recently introduced injectable medications as a new treatment ...

Ed’s stories explore prescription drug pricing, affordability and access, as well issues surrounding patents, litigation and legislation. He is also the author of the morning Pharmalittle newsletter ...